drugset / Trial / NCT05838703
Tiotropium Handihaler vs. Tiotropium Respimat in COPD
Non-randomizedCrossoverOpen-labelTreatment
Summary
The purpose of this study is to determine if tiotropium Respimat will result in better ventilation distribution of the lung in COPD participants quantified by hyperpolarized XeMRI. This study is designed to simulate the real-life clinical setting where patients receive one-time instruction on the inhaler use.
Timeline
- Start
- 2023-05-01
- Primary completion
- 2024-05-01
- Completion
- 2024-05-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Tiotropium | Other / unclassified | — | Inhaled |